Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $364.4400 (-0.01%) ($358.5000 - $367.3700) on Thu. Jan. 12, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 52 | Latest Price | $364.4400(-0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.9% a day on average for past five trading days. | Weekly Trend | REGN declines -1.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) IVW(41%) IWF(41%) | Factors Impacting REGN price | REGN will decline at least -1.405% in a week (0% probabilities). VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) SHY(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $373.03 | 5 Day Moving Average | $363.13(0.36%) | 10 Day Moving Average | $369.75(-1.44%) | 20 Day Moving Average | $373.03(-2.3%) | To recent high | -18% | To recent low | 8.5% | Market Cap | $38.641b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |